Concepedia

Fatty liver and atherogenic dyslipidemia have opposite effects on diabetic micro- and macrovascular disease

Michel P. Hermans, Evariste Bouénizabila, K. Daniel Amoussou-Guenou, Comlan Jules Gninkoun, Sylvie A. Ahn, Michel F. Rousseau

Diabetes & Metabolic Syndrome Clinical Research & Reviews · 2022 · 12 citations · 18 references

DOIFull text

Open access

Concepts

References

18

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

New England Journal of Medicine · 2010 · 1.3K citations · Full text

, , +16

Secondary causes of nonalcoholic fatty liver disease

Jacob M. Kneeman, Joseph Misdraji, Kathleen E. Corey · Therapeutic Advances in Gastroenterology · 2011 · 277 citations · Full text

, , +13

Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy in Type 2 Diabetes Mellitus

Frank M. Sacks, Michel P. Hermans, Paola Fioretto et al. · Circulation · 2013 · 258 citations · Full text

, , +12

Contribution of remnant cholesterol to cardiovascular risk

A. Langsted, Christian M. Madsen, Børge G. Nordestgaard · Journal of Internal Medicine · 2020 · 195 citations · Full text

, , +16

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes.

Michel P. Hermans, J Lévy, R J Morris et al. · Diabetes · 1999 · 187 citations

, , +17